The subgroup C human adenovirus L4 33-kDa protein is a nuclear phosphoprotein that plays a direct, but dispensable, role in virion assembly. The r-strand open reading frame (ORF) for this protein lies opposite to the 5Ј end of the l-strand E2 early (E2E) transcription units. To facilitate studies of regulation of E2E transcription, we wished to construct a mutant virus in which the 33-kDa ORF was truncated to serve as a background into which specific E2E mutations could be introduced without also altering the 33-kDa protein. We constructed viral DNA (vDNA) containing within the 33-kDa ORF two tandem, premature stop codons that should prevent translation of the C-terminal 47 amino acids of the protein (⌬47). We report here the unanticipated lethality of such truncation of the L4 33-kDa protein. Viral DNA harboring the ⌬47 mutations did not produce infectious virus when transfected into cultured cells. In contrast, infectious virus was recovered upon transfection of revertant vDNA, indicating that the ⌬47 mutations were responsible for the observed phenotype. The ⌬47 mutations did not affect E2E transcription or production of the E2 DNA-binding protein. Transfected ⌬47 vDNA was replicated and directed the production of early and late viral proteins, including hexon protein in the trimer conformation. However, no virus particles of any kind were produced. We propose that truncation of the adenovirus 33-kDa protein results in a lethal, late block in the infectious cycle during the assembly of progeny virions and discuss the implications of this phenotype for the mechanism of virion assembly.
INTRODUCTION
The efficient reproduction of human adenovirus type 5 (Ad5) and other members of subgroup C depends on transcriptional and posttranscriptional regulatory mechanisms that ensure that the biosynthetic systems of the host cell produce large quantities of viral structural proteins and DNA genomes for assembly of progeny virus particles (Shenk, 1996) . The majority of viral regulatory proteins begin to be synthesized prior to the onset of viral DNA synthesis in the infected cell. These immediate-early and early adenoviral proteins execute a wide variety of tasks, including activation of transcription from all early promoters, induction of selective export of viral mRNAs from the nucleus during the late phase of infection, provision of countermeasures to host immune responses, reprogramming of the host cell cycle to integrate viral DNA synthesis with entry of the infected cell into S phase, and protection against untimely apoptosis of the host cell (Flint, 1986; Jones, 1995; Nevins, 1992; Shenk, 1996; White, 1995; Wold et al., 1999) . Most viral late proteins, which are made following the initiation of viral DNA synthesis, are structural proteins of virus particles or their precursors, but several are nonstructural proteins that facilitate formation of progeny virions.
Early genetic studies indicated that the L4 100-kDa protein, which is abundant in infected cells, but absent from virus particles, is required for formation of hexon trimers. The 100-kDa protein binds to nascent hexon monomers, but not to the trimeric structural units Sharp, 1982, 1983; Oosterom-Dragon and Ginsberg, 1981) , and therefore is considered an essential chaperone for hexon assembly, one of the initial reactions in formation of virus particles (D'halluin, 1995) . In addition, the L4 100-kDa protein facilitates assembly indirectly, for it is required for efficient initiation of translation of viral late mRNAs (Hayes et al., 1990) . A second product of the major late (ML) transcription unit also participates at an early step in virion assembly. At nonpermissive temperatures, a virus carrying a temperature-sensitive mutation in the coding sequence for the L1 52/55-kDa phosphoproteins accumulated particles termed light intermediates, which are associated with fragments of viral DNA derived from the left end of the genome (Hasson et al., 1989) . This property, and the loss of the 50-100 copies of the proteins in such particles as virions were formed (Hasson et al., 1992) , suggested that the L1 52/55-kDa proteins are required for encapsidation of the viral genome or serve as a temporary scaffold during formation of the capsid. More recently, Imperiale and colleagues have observed that noncomplementing cells infected by a mutant virus null for production of the L1 52/55-kDa proteins produce only empty capsids, with which no associated viral DNA could be detected (Gustin and Imperiale, 1998) . Thus, the primary function of the L1 52/55-kDa proteins appears to be in encapsidation of the viral DNA genome. These proteins interact with a second late protein, the IVa 2 gene product, in yeast, in vitro and in adenovirus-infected cells (Gustin et al., 1996) . The latter protein is the only known sequence-specific DNAbinding protein encoded in the adenoviral genome (Tribouley et al., 1994) and has been implicated (Lutz and Kedinger, 1996; Tribouley et al., 1994) in the 20-to 30-fold stimulation of transcription from the ML promoter characteristic of the late phase of infection (Leong et al., 1990; Mansour et al., 1986; Shaw and Ziff, 1980) . However, the IVa 2 protein was reported over 20 years ago to be associated with putative assembly intermediates, but, like the L1 52/55-kDa proteins to which it binds, much reduced in concentration in, or absent from, virions (Persson et al., 1979) . The notion that the IVa 2 protein is also important for assembly of virus particles has received strong support from the recent observation (Zhang and Imperiale, 2000) that the protein binds specifically in vitro to the packaging signal that directs encapsidation of viral DNA (Hearing et al., 1987; Hearing and Shenk, 1983) .
The L4 region of the Ad5 ML transcription unit includes the coding sequence for a fourth late, nonstructural protein, the 33-kDa protein (Oosterom-Dragon and Anderson, 1983) , originally discovered as a major phosphoprotein made in adenovirus-infected cells (Axelrod, 1978; Gambke and Deppert, 1981a; Russell and Blair, 1977) . Early studies established that this protein is localized to infected cell nuclei (Axelrod, 1978; Cepko and Sharp, 1982; Russell and Blair, 1977) , but is not a component of mature virions (Gambke and Deppert, 1981a, b) . Coding sequences for homologous proteins have been identified in the genomes of other human serotypes (Chroboczek et al., 1992; Davison et al., 1993; Slemenda et al., 1990) and of ovine (Vrati et al., 1995) , murine (Cauthen and Spindler, 1996) , and avian (Cao et al., 1998) adenoviruses. Such conservation suggests that the L4 33-kDa protein fulfills an important function in the viral life cycle, but the first clue about what that role might be was obtained only very recently: introduction of a termination codon in place of that specifying residue 20 of the L4 33-kDa protein of Ad5 reduced the yield of infectious virus some sevenfold, as a result of defective assembly (Fessler and Young, 1999) . The sequence specifying the C-terminus of this L4 protein in the r-strand contains in the l-strand crucial sequences of the early promoter for E2 transcription by RNA polymerase II and the RNA polymerase III transcription unit and promoter that is superimposed on the 5Ј end of the E2E RNA polymerase II transcription unit ( Fig. 1) (Ellsworth et al., 2001; Huang et al., 1994; Pruzan et al., 1992) . This arrangement severely limits genetic analysis of the currently unknown function of E2E RNA polymerase III transcription, as any phenotypes induced by mutations designed to impair transcription or alter the small RNAs made by this enzyme can be interpreted only if the changes do not alter the L4 33-kDa protein coding sequence. In an effort to circumvent this constraint, we introduced mutations designed to prevent translation of the C-terminal 47 amino acids of this protein into the Ad5 genome by homologous FIG. 1. Organization of E2E transcription units and L4 33-kDa protein coding sequences in opposite strands of the Ad5 genome. The viral DNA genome is represented by the pair of solid horizontal lines, the r-and l-strands, in the center of the figure, with the jointed arrow on the l-strand indicating the site of initiation of E2E transcription by RNA polymerase II. The positions of the TATA sequence (gray square) required for efficient transcription by both this enzyme (Shenk and Flint, 1991) and RNA polymerase III (Pruzan et al., 1992) and the t1 and t2 termination sites (Pruzan et al., 1992) recognized by the latter enzyme (gray ovals) are shown to scale. The products of E2E transcription by the two enzymes are listed below, with the 5Ј splice site at the first exon-intron junction in E2E pre-mRNAs marked by the vertical arrowhead. The pale gray arrow drawn above the r-strand indicates the coding sequence for the C-terminal segment of the L4 33-kDa protein (Oosterom-Dragon and Anderson, 1983) , with the truncated coding sequence present in the r-strand of the ⌬47 mutant genome shown above. The wild-type sequence spanning the positions of the ⌬47 mutations (bp 26,941 to 26,963) is listed above, with the changes that introduce tandem stop codons indicated in the top line. The r-strand sequence underlined is the complement of the t2 site of termination of RNA polymerase III transcription. recombination in Escherichia coli and attempted to recover the mutant virus. We report here the unanticipated lethality of this alteration in the L4 33-kDa protein and discuss the implications of the defects in virus particle production induced by the mutations for mechanisms of adenovirus assembly.
RESULTS

Considerations in designing the ⌬47 mutations
The complex E2E transcriptional control region of subgroup C human adenoviruses was the first demonstrated to direct transcription in vivo by both RNA polymerase II and RNA polymerase III (Huang et al., 1994) . In an attempt to create an appropriate background for genetic analysis of the functional significance of this unusual arrangement, we introduced into the L4 33-kDa protein coding sequence two premature tandem stop codons that should prevent synthesis of the C-terminal 47 amino acids (⌬47; Fig. 1 ). Two stop codons were introduced to minimize the possibility that revertant viruses would arise during infection. The ⌬47 mutations lie downstream of the E2E RNA polymerase III t2 termination site at ϩ90 and are also well removed from the internal sequence of the RNA polymerase II and RNA polymerase III promoters that we have recently defined (Ellsworth et al., 2001) , as well as from the first 5Ј splice site of RNA polymerase II transcripts (Fig. 1) .
The ⌬47 mutations do not alter E2E transcription in vitro
To investigate whether the ⌬47 mutations disrupted some previously unrecognized l-strand transcriptional control sequence, E2E transcription from wild-type and ⌬47 templates was compared in in vitro reactions specific for RNA polymerase II or RNA polymerase III. These templates contained a mutation that eliminates the t1 termination site of the RNA polymerase III transcription unit ( Fig. 1) , so that the latter enzyme synthesizes a single transcript. This change facilitates quantitative analyses, but does not alter the efficiency of transcription (Ellsworth et al., 2001) . Transcripts synthesized from the wild-type and ⌬47 templates by the two enzymes were detected by primer extension and quantified as described under Materials and Methods. As illustrated in Fig. 2 , the ⌬47 mutations did not lead to major changes in the efficiency of E2E transcription by either RNA polymerase II or RNA polymerase III (Fig. 2) , giving us greater confidence that they would not disrupt E2E transcription in vivo.
The ⌬47 mutant genome is unable to produce virus in cultured human cells
One of the advantages of using a plasmid-based system for introduction of mutations into viral genomes is that the homologous recombination step that moves the desired mutation(s) into viral DNA is carried out in bacteria. Thus, the presence of the mutation can be confirmed prior to introducing vDNA into permissive host cells. Consequently, lethal mutations can be readily recognized as successful transfections that do not yield infectious virus.
Attempts to recover ⌬47 virus by transfecting 100-mm dishes of 293 cells with 2 g vDNA cleaved from pTG3602/⌬47 were repeatedly unsuccessful. Cells transfected with ⌬47 vDNA did not exhibit an obvious cytopathic effect (CPE) ( Table 1 ) and extracts prepared from them failed to infect 293 cells. By contrast, 293 cells b Final titers were determined after complete CPE was observed or at 14 days posttransfection in the case of cells receiving ⌬47 DNA alone. Cells and medium were harvested together and subjected to five freeze/thaw cycles. Cellular debris was removed by centrifugation and the supernatants were titered in duplicate by plaque assay on 293 cells.
c CPE was not detectable (ND).
FIG. 2. E2E transcription in vitro from
wild-type and ⌬47 templates. Transcription of the templates by RNA polymerase II or III, primer extension, and analysis and quantification of cDNAs synthesized from E2E transcripts were as described under Materials and Methods. The efficiency of transcription of the ⌬47 template is expressed relative to that of the wild type, set at 1.0. These values represent the means of three independent experiments. transfected with 2 g wild-type vDNA cleaved from pTG3602 included as a control in each experiment developed detectable and complete CPE by 3 to 4 days and 7 to 8 days, respectively, posttransfection and yielded infectious virus (Table 1) . Several approaches were taken to eliminate technical problems as the reason for the failure to recover the ⌬47 mutant virus. The vDNA preparations were routinely analyzed by gel electrophoresis to ensure that the quality and quantity of ⌬47 and wild-type vDNAs were comparable. Transfection efficiency was monitored by inclusion of a plasmid directing synthesis of the green fluorescent protein, pEGFP-N1 DNA (Clontech, Palo Alto, CA), in each transfection. When the expression of this protein in wild-type and ⌬47 transfections was compared at 24 h posttransfection, no differences in transfection efficiencies (20 to 30%) were apparent (data not shown). In addition, adenovirus early protein synthesis was examined in transfected HeLa cells by indirect immunofluorescence labeling with monoclonal antibodies recognizing the E1A or the E1B 55-kDa proteins. Both early proteins were detected in the nucleus of cells transfected with either wild-type or ⌬47 vDNA by 48 h posttransfection (Fig. 3) . This result demonstrated directly that the efficiency of transfection of vDNA was similar for the wild-type and ⌬47 genomes and also indicated that early protein production is not affected by the ⌬47 mutations.
To determine whether the mutant genome harbored any other defect(s) that would impair virus growth, a revertant virus (⌬47rev2) was isolated by cotransfecting a DNA fragment containing the wild-type sequence spanning the ⌬47 mutations with ⌬47 vDNA (Table 1 ). This revertant virus exhibited wild-type growth characteristics (Fig. 4) and plaque morphology similar to that of the wild type (data not shown). Revertant vDNA was also constructed by rescuing SpeI-cut pTG3602/⌬47 with a DNA fragment containing the wild-type sequence. Revertant vDNA was as infectious as wild-type vDNA in transfection experiments (Table 2 ) and the virus recovered (⌬47rev1) also exhibited wild-type growth characteristics (Fig. 4) . Thus, the inability of ⌬47 vDNA to yield infectious virus in transfections can be attributed to the introduced mutations.
Early and late viral proteins are produced from transfected ⌬47 vDNA
The results described in the previous section indicate that ⌬47 vDNA was able to direct the production of adenovirus early E1A and E1B 55-kDa proteins with kinetics and efficiency similar to those observed in cells transfected with wild-type vDNA. In an effort to determine the point at which the viral life cycle was blocked by FIG. 4 . Single-step growth curves of wild-type and ⌬47 revertant viruses. Confluent 60-mm dishes of 293 cells were infected at a multiplicity of infection of 10. At various times postinfection, cells and medium were harvested together, and virus was released and quantified as described in the footnotes to Table 1 .
FIG. 3.
Mutant vDNA can direct the production of E1A and E1B 55-kDa proteins. HeLa cells were transfected with 0.5 g wild-type or ⌬47 vDNA and labeled with monoclonal antibodies recognizing the proteins indicated and fluorescein isothiocyanate-conjugated secondary antibody, as described under Materials and Methods. Representative fields are shown.
these mutations, we examined the production of other viral proteins by indirect immunofluorescence microscopy. 293 cells were transfected with wild-type or ⌬47 vDNA and labeled with monoclonal antibodies recognizing the E2 72-kDa DNA-binding protein (DBP), the L4 100-kDa protein, or the hexon protein in the trimer confirmation, and an FITC-conjugated secondary antibody. The number of cells stained for each protein per field was similar in cells transfected with wild-type and ⌬47
vDNA at 48 h posttransfection (Fig. 5) . The mRNA specifying the DBP is processed from primary transcripts synthesized from the E2E RNA polymerase II promoter (Shenk, 1996) . The production of DBP in cells transfected with ⌬47 mutant vDNA therefore provides further reassurance that E2E transcription was not significantly altered by the ⌬47 mutations. The ability of ⌬47 vDNA to direct the synthesis of viral late proteins, including at least one structural protein, indicated that the block to virus replication occurred late in the infectious cycle.
The DBP-specific monoclonal antibodies used in these assays (A1) recognize only the native, functional form of the protein (Reich et al., 1983) . In high multiplicity infections of HeLa cells analyzed during the late phase of infection, these antibodies detect native DBP as distinct spots within the nucleus (Ornelles and Shenk, 1991; Voelkerding and Klessig, 1986) . Similar punctate nuclear staining was observed in some cells transfected with both wild-type and ⌬47 vDNA (Fig. 5 ). However, diffuse nuclear staining was also apparent in other cells that received either wild-type or ⌬47 DNA (Fig. 5 ). This difference in staining patterns within the populations of cells making the DBP is most likely the result of asynchronous initiation of infectious cycles when the viral genome is introduced by transfection. 
Replication of ⌬47 vDNA is delayed
During productive adenovirus infection, phase-dense, vesicular structures with which the punctate DBP detected by indirect immunofluorescence coincides are formed in the nucleus (Ornelles and Shenk, 1991; Reich et al., 1983; Sugawara et al., 1977; Voelkerding and Klessig, 1986 ). These structures also contain newly replicated viral DNA MartinezPalomo and Granboulan, 1967; Moyne et al., 1978; reviewed in Bridge and Pettersson, 1995) . The punctate nuclear staining pattern exhibited by the DBP-specific monoclonal antibodies in cells transfected with ⌬47 vDNA (Fig. 5) indicated that centers of viral replication were established. To complement this observation, we wished to examine ⌬47 vDNA replication by a more direct means. We therefore monitored viral replication using sensitivity to the restriction endonuclease DpnI to distinguish input vDNA made in E. coli (sensitive) from replicated viral DNA (resistant) (Hay, 1985) . Low-molecular-weight DNA was isolated from 293 cells transfected with either wild-type or ⌬47 vDNA by a modified Hirt lysis procedure (see Materials and Methods) and analyzed by Southern blotting following cleavage with KpnI or KpnI and DpnI. In cells transfected by wild-type vDNA, DpnIresistant, replicated vDNA was routinely detected by 12 h posttransfection (Fig. 6A) . The fraction of such DpnIresistant DNA increased thereafter, with the concomitant appearance of diffuse, low-mobility viral DNA (Fig. 6A ) that presumably represents replication intermediates containing single-stranded DNA (Lechner and Kelly, 1977; Van Der Vliet, 1995) . Similar results were obtained with probes detecting L4 (Fig. 6 ) on E4 (data not shown) viral DNA sequences. In contrast, DpnI-resistant viral DNA was not detected in cells transfected with ⌬47
vDNA until 24 h posttransfection and remained at lower concentrations than wild-type vDNA-containing cells throughout the period examined (Fig. 6B ). This delay in the onset of viral DNA synthesis and accumulation of replicated DNA was observed in several independent experiments in which wild-type DNA and ⌬47 vDNA were introduced into 293 cells in parallel. However, we observed considerable variability in the fraction of DpnIresistant DNA appearing in the specific intervals posttransfection examined in both wild-type and ⌬47 transfections (for example, compare the 48-h wild-type samples in Figs. 6A and 6B). It seems likely that such variability is in large measure the result of the asynchrony among infectious cycles established in individual cells, when viral genomes are introduced by transfection rather than by virus infection. A second parameter that precluded quantitative comparison of the replication of the wild-type and ⌬47 genomes was the fact that infectious virus, which can infect new host cells in the population (also asynchronously), was produced following transfection of the former but not the latter vDNA (Table  1) . Despite these limitations, we can conclude that ⌬47 vDNA can be replicated and that its replication is delayed compared to that of wild-type vDNA (Fig. 6 ).
Assembly of virus particles is defective in ⌬47 vDNAtransfected cells
The ability of the ⌬47 genome to direct the production of viral late proteins, including at least one structural protein, and to be replicated, yet yield no infectious virus prompted us to examine assembly of virus particles. Cells were transfected with wild-type, ⌬47, or revertant vDNA and harvested at 5 days posttransfection. This period was empirically determined to allow production of a sufficient number of wild-type virus particles for ready visual detection in CsCl density gradients, which were used to separate virions from less dense empty particles. Both types of particle were present in lysates of cells transfected with either wild-type or ⌬47rev1 vDNA, with virions predominating (Fig. 7) . In contrast, no particles whatsoever could be seen in gradients to which lysates of ⌬47 vDNA-transfected cells were applied (Fig. 7) . Thus, the mutations introduced into the ⌬47 genome induced an apparently total block to assembly of virus particles.
DISCUSSION
Truncation of the Ad5 L4 33-kDa protein 47 amino acids before the C-terminus completely inhibited virus replication (Tables 1 and 2 ). This lethal phenotype can be attributed to the introduced mutations, for revertant viruses isolated by two different methods displayed wildtype growth characteristics (Fig. 4) and ⌬47 rev1 vDNA directed the production of similar quantities of empty capsids and virions as wild-type vDNA (Fig. 7) . In designing the ⌬47 mutations, we avoided disrupting any known splicing and transcriptional control signals, including the recently described intragenic promoter sequences of the l-strand E2E RNA polymerase II and RNA polymerase III transcription units (Ellsworth et al., 2001) . The results of in vitro transcription assays (Fig. 2) as well as our ability to detect the E2 72-kDa DBP in cells transfected with ⌬47 vDNA (Fig. 5) indicate that, as anticipated, E2E transcription was unaffected by these mutations. Nor did the ⌬47 mutations interfere with production of the L4 100-kDa protein, as its synthesis and assembly of hexon trimers, which requires the 100-kDa protein (see Introduction), were comparable in cells transfected with Ad5 and ⌬47 vDNAs (Fig. 5) .
Despite the block to production of infectious virus particles (Tables 1 and 2 ), the ⌬47 mutations did not prevent synthesis of viral late proteins or formation of intranuclear, E2 72-kDa DBP-containing structures with the characteristic appearance of replication centers (Fig.  5) . Accumulation of newly synthesized viral DNA was delayed in ⌬47 compared to Ad5 vDNA-transfected cells (Fig. 6) . However, this reduction in concentration of progeny viral genomes was much less than that of virus particles, which could not be detected by either biological or physical assays (Tables 1 and 2, Fig. 7 ). These properties therefore led us to conclude that truncation of the L4 33-kDa protein resulted in a lethal failure in assembly of progeny virions. The conclusion that the 33-kDa protein functions during adenovirus assembly is consistent with a previous report that introduction of a stop codon at position 20 in the coding sequence specifically impairs accumulation of viral particles, particularly of those containing the viral genome (Fessler and Young, 1999) . In this study, the point in the assembly pathway at which the L4 33-kDa protein acts could not be identified. The results reported here establish that this protein must participate very early in assembly, for the ⌬47 mutations blocked formation of all types of virus particle (Fig. 7) . Furthermore, the L4 33-kDa protein must act earlier in the assembly pathway than the L1 52/55-kDa proteins, for empty capsids are still formed in cells infected by a mutant virus null for production of this L1 protein (Gustin and Imperiale, 1998) .
The lethality associated with the ⌬47 mutations was surprising, as Fessler and Young (1999) observed that elimination of synthesis of the L4 33-kDa protein in infected cells reduced virus yield only some sevenfold. One possible explanation for the much more severe defect induced by the ⌬47 mutations is that the truncated 33-kDa protein lacking the C-terminal 47 residues represents a dominant, negative form. Although cotransfection of wild-type and ⌬47 genomes yielded no clear evidence for such dominance, the limitations of this approach discussed previously make it difficult to exclude this possibility. Alternatively, it may be that transient interactions of the L4 33-kDa protein with one or more virion components and/or with other nonstructural proteins participating in assembly mediate the early assembly function of this L4 protein, but are rendered irreversible in the absence of the C-terminal portion of the protein. Be that as it may, it is clear that the C-terminal segment of the 33-kDa protein includes a crucial functional domain. In this context, it is noteworthy that threepotential sites of phosphorylation are removed in the truncated, ⌬47 form of the protein. From a more general perspective, the inability of this truncated form of the 33-kDa protein to participate in productive assembly reaction is not unexpected. A central idea in macromolecular assembly is that removal of C-terminal amino acids renders proteins incompetent for proper assembly, providing a quality control mechanism to minimize assembly errors that could arise from the participation of N-terminal protein fragments (Casjens, 1997) . This hypothesis has been experimentally verified in the case of viral structural proteins (Garcea et al., 1987) as well as for viral scaffolding proteins (Casjens, 1997) , one of the potential roles proposed for the 33-kDa protein (Fessler and Young, 1999) .
Two general mechanisms of assembly of DNA-containing virions can be distinguished by the criterion of whether capsid assembly is coordinated with, or precedes, genome encapsidation. During sequential assembly, a mechanism epitomized by double-stranded DNA bacteriophage, such as T4, , and P22, a stable capsid shell (the procapsid) is formed prior to entry of the genome. In all such phage assembly pathways, scaffolding proteins guide assembly of the procapsid and are removed early in packaging of the viral DNA (see Casjens and Hendrix, 1988; King and Chiu, 1997) . Among animal viruses with DNA genomes, herpesviruses clearly assemble by this mechanism (see Steven and Spear, 1997) . Adenoviruses have also been considered to assemble in this way (see, for example, D 'halluin, 1995; Shenk, 1996) . Such a sequential assembly model is based on several lines of evidence. These include the production in infected cells of large quantities of empty capsids that lack viral DNA and internal core proteins (Anderson et al., 1973; Ishibashi and Maizel, 1974; Maizel et al., 1968; Oberg et al., 1975; Prage et al., 1972; Sundquist et al., 1973) ; the presence in these particles of several proteins absent from, or much reduced in concentration in, mature virions, including the L1 52/55-kDa and IVa 2 proteins (Evardsson et al., 1976; Hasson et al., 1992; Ishibashi and Maizel, 1974; Persson et al., 1979; Prage et al., 1972; Rosenwirth et al., 1974; Sundquist et al., 1973; Winter and D'halluin, 1991) ; the detection of small quantities of labile particles associated with viral DNA fragments or the intact viral genome, termed light and heavy intermediates, respectively (D'halluin et al., 1978; Evardsson et al., 1976) ; and the partial chase of label initially detected in light particles to heavy particles and virions during pulse-chase labeling (D'halluin et al., 1978; Evardsson et al., 1976) . According to a sequential assembly model, the failure of ⌬47 vDNA-transfected cells to accumulate detectable quantities of empty capsids (Fig. 7) suggests that the L4 33-kDa protein functions as a classical scaffolding protein, required for assembly and/or stabilization of the capsid shell.
This model for adenovirus assembly rests on the assumption that extraction from infected cells and purification of the proposed precursor and intermediate particles do not alter their composition or structure. The structure designated the light intermediate cannot be a bona fide intermediate in assembly of virions: as discussed above, it lacks the complete genome. This particle may be formed from a true intermediate in which the associating DNA is susceptible to breakage, but the possibility that it is the result of more substantial alterations has not been excluded. In addition, experience in other viral systems indicates that even stable, incomplete particles that accumulate to high concentrations such as empty capsids are not necessarily precursors to virions. The 75S empty capsid of poliovirus, initially considered a precursor into which the viral RNA genome was inserted (Jacobson and Baltimore, 1968) , cannot associate with the viral genome (Nugent and Kirkegaard, 1995) and forms in a cell-free system for poliovirus replication only when the concentration of viral RNA is low (Verlinden et al., 2000) . Thus, these structures are dead-end products or perhaps a storage form of the 14S pentamers from which RNAcontaining provirions are assembled (see Verlinden et al., 2000) . Finally, a sequential mechanism of adenovirus assembly predicts that deletion of the packaging signal, which lies near the left end of the viral genome (Hammarsköld and Winburg, 1980; Hearing et al., 1987; Hearing and Shenk, 1983) , would prevent formation of virions, but have no effect on assembly of empty capsids. However, deletion of the packaging signal of Ad5 blocked assembly of all virus particles, including empty capsids (cited in Hasson et al., 1992; Hearing and Shenk, 1983) , indicating that assembly of the capsid shell must require recognition of the DNA packaging signal by one or more viral proteins. Thus, a mechanism of adenovirus assembly in which capsid formation is coordinated with genome encapsidation appears plausible. The empty capsids that accumulate during the Ad5 infectious cycle and in the absence of the L1 52/55-kDa proteins would be dead-end products, analogous to those formed in poliovirus-infected cells (see above). In this case, the absence of empty capsids in ⌬47 vDNA-transfected cells would implicate the L4 33-kDa protein in initiating coordination of encapsidation of the genome with capsid formation, perhaps by recruiting the L1 52/55-kDa and/or IVa 2 proteins believed to mediate encapsidation of viral DNA (Gustin et al., 1996; Zhang and Imperiale, 2000) .
MATERIALS AND METHODS
Cells and viruses
293 cells were used for routine propagation of viruses, plaque assays, and transfections. The transfection efficiency achieved in 293 cells was routinely 20-30%. Immunofluorescence assays for the E1A and E1B 55-kDa proteins, which are made in 293 cells from integrated viral DNA (Aiello et al., 1979) , were carried out in HeLa cells. Large-scale, high-titer viral stocks were prepared following low-multiplicity infection of HeLa cells in suspension culture as described (Flint et al., 1975) . Both 293 and HeLa cell monolayers were maintained in Dulbecco's modified Eagle's medium containing 10% calf serum; HeLa cells in suspension were maintained in minimum essential medium containing 5% calf serum. Transfection of 293 or HeLa cells was carried out using the calcium phosphate precipitation technique originally described by Graham and Van der Eb (1973) . The time posttransfection is defined as the period elapsed following replacement of the medium after incubation of cells for a sufficient period to allow uptake of the DNA precipitate (usually overnight). Viral DNA introduced into human cells was prepared by digestion of pTG3602-based plasmids (see next section) with PacI (Chartier et al., 1996) .
Construction of the ⌬47 mutant and ⌬47 revertants
Two tandem stop codons that should prevent translation of the C-terminal 47 amino acids of the L4 33-kDa protein ( Fig. 1) were introduced by site-directed mutagenesis using the pAlter system (Promega, Madison, WI) into a HindIII/ PstI fragment comprising positions 26,328 to 27,684 in the Ad5 genome. The entire HindIII/PstI fragment was sequenced to confirm the introduction of these ⌬47 mutations but no additional alterations in the DNA sequence. The mutations were then introduced into the viral genome by homologous recombination in E. coli using pTG3602, a plasmid that contains the entire Ad5 genome bracketed by PacI sites, and the method described by Chartier et al. (1996) . We took advantage of the unique SpeI site located within the E2E transcription unit and used the HindIII/PstI fragment containing the ⌬47 mutations to rescue SpeIdigested pTG3602. The introduction of the ⌬47 mutations into pTG3602 (pTG3602/⌬47) was confirmed by sequencing a PCR product spanning the region of interest amplified from rescued pTG3602. The ⌬47 revertant DNA was obtained in a similar manner, using a wild-type HindIII/BglII fragment encompassing bp 26,328 to 28, 133 of the Ad5 genome to rescue SpeI-digested pTG3602/⌬47. The virus subsequently recovered from pTG3602/⌬47rev1 DNA is referred to as ⌬47rev1. A second revertant virus (⌬47rev2) was obtained by cotransfecting 293 cells with the wild-type HindIII/BglII fragment and ⌬47 vDNA. The introduction of the wild-type sequences was confirmed by sequencing PCR products spanning the region of interest amplified from pTG3602/⌬47rev1 or from viral DNA purified from ⌬47rev2.
Indirect immunofluorescence assays
Cells used in indirect immunofluorescence assays were grown on 22-mm round glass coverslips (Fisher) placed inside a well of a 6-well tissue culture dish. To improve the adherence of 293 cells in these assays, the coverslips were pretreated with 0.01% poly-L-lysine according to the manufacturer's instructions (Sigma, St.
Louis, MO). vDNA (0.5 g) was introduced into the cells in each well as described above. At 48 h posttransfection, cells were fixed by incubation with 2 ml per well of freshly prepared 4% paraformaldehyde in phosphatebuffered saline (PBS) for 10 min at room temperature. Fixed cells were washed 3 times with PBS containing 0.5% bovine serum albumin (PBS/BSA; 2 ml per well) and permeabilized for 3 min at room temperature with PBS containing 0.1% Triton X-100 (1 ml per well). Fixed, permeabilized cells were washed 3 times with PBS/BSA and incubated overnight at 4°C with 1 ml of monoclonal hybridoma supernatant diluted 1/100 in PBS/BSA. The specific monoclonal hybridoma supernatants used were as follows: for E1A proteins, M73 (Harlow et al., 1985) ; for the E1B 55-kDa protein, 2A6 (Sarnow et al., 1982) ; for the E2E 72-kDa DNA-binding protein, A1 (Reich et al., 1983) ; for the L4 100-kDa protein, 2-100K (Cepko et al., 1981; Cepko and Sharp, 1983) ; and for hexon in the trimer conformation, 2Hx-2 (Cepko and Sharp, 1982) . Cells were then washed 3 times with PBS/BSA, and 150 l of the secondary antibody, fluorescein isothiocyanate-(FITC-) conjugated donkey anti-mouse IgG, prepared and diluted according to the manufacturer's instructions (Jackson ImmunoResearch Laboratories, West Point, PA), was applied directly to the coverslips. Cells were then incubated for 60 min at 37°C in a humid chamber, washed 3 times with 2 ml of PBS, and mounted in PBS containing 50% (v/v) glycerol onto glass slides. Samples were examined using a Nikon epifluorescence microscope equipped with a cooled CCD camera. Composites of representative images were prepared using Adobe Photoshop software.
In vitro transcription assays
RNA polymerase II-and RNA polymerase III-specific in vitro E2E transcription in HeLa cell whole-cell (Leong and Flint, 1984) and nuclear (Dignam et al., 1983) extracts, respectively, was analyzed under the conditions described previously (Ellsworth et al., 2001) . The wildtype E2E template DNA (pHE2E⌬t1P) comprised positions 26,328 to 27,684 of the Ad5 genome with a mutation that eliminates the first E2E RNA polymerase III termination signal, t1 (see Fig. 1 ), in the pAlter-1 vector. The mutant template (pHE2E⌬t1P/⌬47) differed from wild type only in C to T and G to T changes at bp 26,943 and 26,946, respectively (Fig. 1) . E2E transcripts were detected using an end-labeled oligonucleotide complementary to positions ϩ65 to ϩ85 of the transcription unit in primer extension assays as described (Ellsworth et al., 2001) . The products of primer extension were separated by electrophoresis in 6% denaturing polyacrylamide gels (Kasai et al., 1992) and the signal corresponding to the 85-nucleotide E2E cDNA was quantified by PhosphorImager analysis (Molecular Dynamics).
Viral DNA replication analysis Viral DNA was extracted from 100-mm dishes of 293 cells transfected with 2 or 2.5 g of vDNA using a modification of the Hirt cell lysis procedure (Hirt, 1967) . At various times posttransfection, cells were washed with 5 ml of PBS and then incubated with 1 ml of 0.01 M EDTA, pH 7.5, containing 0.6% (w/v) SDS for 20 min at room temperature. Cell lysates were collected and incubated for 8 h at 4°C following addition of NaCl to a final concentration of 1 M. Lysates were then centrifuged at 12,000 rpm for 30 min at 4°C, and the supernatants were diluted 1:5 with 0.01 M Tris-HCl, pH 7.5. Diluted supernatants were incubated sequentially for 30 min at 37°C with 20 g/ml RNase and 1 mg/ml proteinase K and the DNA was purified by two phenol/chloroform extractions and two chloroform extractions. The DNA was precipitated by the addition of 2.5 vol of ethanol and 5 g/ml tRNA carrier. DNA precipitates were collected and resuspended in 100 l H 2 O, and portions of each sample were digested with either KpnI or KpnI plus DpnI to distinguish input DNA from replicated viral DNA. Digested DNAs were electrophoresed through 0.6% agarose gels cast and run in 0.45 M Tris-borate, pH 8.0, and transferred to Zeta probe membranes (Bio-Rad) by alkaline capillary transfer for 16 h according to the manufacturer's instructions. Membranes were washed twice in 0.03 M sodium citrate, pH 6.8, containing 0.3 M NaCl (2ϫ SSC) and prehybridized by incubation with 0.25 M Na 2 HPO 4 , pH 7.2, containing 1 mM EDTA and 7% (w/v) SDS (Church and Gilbert, 1984) for 30 min at 65°C. They were then hybridized in the same buffer with 32 P-labeled, denatured E4 ORF 6 or L4 33-kDa coding sequence DNA for 16 h at 65°C. The viral DNAs were excised from plasmid vectors, purified by gel electrophoresis, and labeled by random primed DNA synthesis using [␣- 32 P]dCTP (300 Ci/ mmol New England Nuclear-Dupont) as described (Feinberg and Vogelstein, 1984) . Membranes were washed 4 times for 20 min at 55°C in 1ϫ SSC containing 0.5% (w/v) SDS and exposed to Kodak XA/R film or to a PhosphorImager (Molecular Dynamics) screen.
Analysis of virion assembly
To prepare samples for examination of virus particles by centrifugation to equilibrium in CsCl density gradients, ten 100-mm dishes of 293 cells were transfected with 2 g per dish vDNA, prepared as described above. The cells were harvested at 5 days posttransfection, washed twice with 10 ml of PBS, resuspended in 3 ml of 0.025 M Tris-HCl, pH 7.4, containing 0.15 M NaCl, 5 mM KCl, 0.55 mM Na 2 HPO 4 , and 0.1% (w/v) dextrose, and subjected to five freeze/thaw cycles. Cellular debris was removed by centrifugation and 2.5 ml of each lysate was loaded onto a preformed 1.4 to 1.2 g/cm 3 CsCl gradient. A portion of each lysate (400 l) was retained for titration by plaque assay. Gradients were centrifuged at 35,000 rpm for 16 h at 4°C and photographed.
